Literature DB >> 18774292

Dual DAT/sigma1 receptor ligands based on 3-(4-(3-(bis(4-fluorophenyl)amino)propyl)piperazin-1-yl)-1-phenylpropan-1-ol.

Jianjing Cao1, Theresa Kopajtic, Jonathan L Katz, Amy Hauck Newman.   

Abstract

Ester analogs of (+/-)3-(4-(3-(bis(4-fluorophenyl)amino)propyl)piperazin-1-yl)-1-phenylpropan-1-ol were synthesized and evaluated for binding at DAT, SERT, NET, and sigma1 receptors, and compared to GBR 12909 and several known sigma1 receptor ligands. Most of these compounds demonstrated high affinity (K(i)=4.3-51 nM) and selectivity for the DAT among the monoamine transporters. S- and R-1-(4-(3-(bis(4-fluorophenyl)amino)propyl)piperazin-1-yl)-3-phenylpropan-2-ol were also prepared wherein modest enantioselectivity was demonstrated at the DAT. However, no enantioselectivity at sigma1 receptors was observed and most of the ester analogs of the more active S-enantiomer showed comparable binding affinities at both DAT and sigma1 receptors with a maximal 16-fold DAT/sigma1 selectivity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18774292      PMCID: PMC3393102          DOI: 10.1016/j.bmcl.2008.08.065

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  17 in total

1.  Structure-activity relationships at the monoamine transporters and sigma receptors for a novel series of 9-[3-(cis-3, 5-dimethyl-1-piperazinyl)propyl]carbazole (rimcazole) analogues.

Authors:  S M Husbands; S Izenwasser; T Kopajtic; W D Bowen; B J Vilner; J L Katz; A H Newman
Journal:  J Med Chem       Date:  1999-10-21       Impact factor: 7.446

2.  Rimcazole analogs attenuate the convulsive effects of cocaine: correlation with binding to sigma receptors rather than dopamine transporters.

Authors:  R R Matsumoto; K L Hewett; B Pouw; W D Bowen; S M Husbands; J J Cao; A H Newman
Journal:  Neuropharmacology       Date:  2001-12       Impact factor: 5.250

3.  [3-cis-3,5-Dimethyl-(1-piperazinyl)alkyl]-bis-(4'-fluorophenyl)amine analogues as novel probes for the dopamine transporter.

Authors:  J Cao; S M Husbands; T Kopajtic; J L Katz; A H Newman
Journal:  Bioorg Med Chem Lett       Date:  2001-12-17       Impact factor: 2.823

4.  Involvement of the sigma(1) receptor in cocaine-induced conditioned place preference: possible dependence on dopamine uptake blockade.

Authors:  Pascal Romieu; Vân Ly Phan; Rémi Martin-Fardon; Tangui Maurice
Journal:  Neuropsychopharmacology       Date:  2002-04       Impact factor: 7.853

Review 5.  Sigma(1) (sigma(1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity.

Authors:  Tangui Maurice; Rémi Martin-Fardon; Pascal Romieu; Rae R Matsumoto
Journal:  Neurosci Biobehav Rev       Date:  2002-06       Impact factor: 8.989

6.  Behavioral effects of rimcazole analogues alone and in combination with cocaine.

Authors:  Jonathan L Katz; Therissa A Libby; Theresa Kopajtic; Stephen M Husbands; Amy Hauck Newman
Journal:  Eur J Pharmacol       Date:  2003-05-09       Impact factor: 4.432

7.  Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.

Authors:  William J Houlihan; Lawrence Kelly; Jessica Pankuch; Judith Koletar; Leonard Brand; Aaron Janowsky; Theresa A Kopajtic
Journal:  J Med Chem       Date:  2002-09-12       Impact factor: 7.446

Review 8.  Probes for the dopamine transporter: new leads toward a cocaine-abuse therapeutic--A focus on analogues of benztropine and rimcazole.

Authors:  Amy Hauck Newman; Santosh Kulkarni
Journal:  Med Res Rev       Date:  2002-09       Impact factor: 12.944

9.  Design and synthesis of 2- and 3-substituted-3-phenylpropyl analogs of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine: role of amino, fluoro, hydroxyl, methoxyl, methyl, methylene, and oxo substituents on affinity for the dopamine and serotonin transporters.

Authors:  Ling-Wei Hsin; Li-Te Chang; Richard B Rothman; Christina M Dersch; Arthur E Jacobson; Kenner C Rice
Journal:  J Med Chem       Date:  2008-04-05       Impact factor: 7.446

10.  Dual probes for the dopamine transporter and sigma1 receptors: novel piperazinyl alkyl-bis(4'-fluorophenyl)amine analogues as potential cocaine-abuse therapeutic agents.

Authors:  Jianjing Cao; Santosh S Kulkarni; Stephen M Husbands; Wayne D Bowen; Wanda Williams; Theresa Kopajtic; Jonathan L Katz; Clifford George; Amy Hauck Newman
Journal:  J Med Chem       Date:  2003-06-19       Impact factor: 7.446

View more
  5 in total

1.  Ether modifications to 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine (SA4503): effects on binding affinity and selectivity for sigma receptors and monoamine transporters.

Authors:  Rong Xu; Sarah A Lord; Ryan M Peterson; Emily A Fergason-Cantrell; John R Lever; Susan Z Lever
Journal:  Bioorg Med Chem       Date:  2014-11-11       Impact factor: 3.641

2.  Chlorophenylpiperazine analogues as high affinity dopamine transporter ligands.

Authors:  William C Motel; Jason R Healy; Eddy Viard; Buddy Pouw; Kelly Martin; Rae R Matsumoto; Andrew Coop
Journal:  Bioorg Med Chem Lett       Date:  2013-10-15       Impact factor: 2.823

3.  Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors.

Authors:  Jianjing Cao; Rachel D Slack; Oluyomi M Bakare; Caitlin Burzynski; Rana Rais; Barbara S Slusher; Theresa Kopajtic; Alessandro Bonifazi; Michael P Ellenberger; Hideaki Yano; Yi He; Guo-Hua Bi; Zheng-Xiong Xi; Claus J Loland; Amy Hauck Newman
Journal:  J Med Chem       Date:  2016-11-28       Impact factor: 7.446

4.  New Drugs, Old Targets: Tweaking the Dopamine System to Treat Psychostimulant Use Disorders.

Authors:  Amy Hauck Newman; Therese Ku; Chloe J Jordan; Alessandro Bonifazi; Zheng-Xiong Xi
Journal:  Annu Rev Pharmacol Toxicol       Date:  2021-01-06       Impact factor: 16.459

5.  Novel Highly Potent and Selective Sigma1 Receptor Antagonists Effectively Block the Binge Eating Episode in Female Rats.

Authors:  Carlo Cifani; Emanuela Micioni Di Bonaventura; Luca Botticelli; Fabio Del Bello; Gianfabio Giorgioni; Pegi Pavletić; Alessandro Piergentili; Wilma Quaglia; Alessandro Bonifazi; Dirk Schepmann; Bernhard Wünsch; Giulio Vistoli; Maria Vittoria Micioni Di Bonaventura
Journal:  ACS Chem Neurosci       Date:  2020-09-21       Impact factor: 4.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.